logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12161642 B1

PDFFull Text
Date of Patent:
Dec. 10, 2024

Filed:

Apr. 30, 2019

Ferrochelatase inhibitors and methods of use

Applicants:

Indiana University Research and Technology Corporation, Indianapolis, IN (US);

Gachon University of Industry-academic Cooperation, Gyeonggi-do, KR;

Inventors:

Timothy W. Corson, Fishers, IN (US);

Kamakshi Sishtla, Indianapolis, IN (US);

Seung-Yong Seo, Gyeonggi-do, KR;

Bit Lee, Gyeonggi-do, KR;

Assignees:

INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION, Indianapolis, IN (US);

Gachon University of Industry—Academic Cooperation, Gyeonggi-do, KR;

Attorney:

Barnes & Thornburg LLP

Primary Examiner:

Peter J Reddig

Assistant Examiner:

Cheng Lu

Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61K 31/122 (2006.01); A61K 31/155 (2006.01); A61K 31/343 (2006.01); A61K 31/37 (2006.01); A61K 31/4025 (2006.01); A61K 31/409 (2006.01); A61K 31/4196 (2006.01); A61K 31/4706 (2006.01); A61K 31/4709 (2006.01); A61K 31/49 (2006.01); A61K 38/17 (2006.01); A61K 39/395 (2006.01); A61K 41/00 (2020.01); A61K 45/06 (2006.01); A61P 27/02 (2006.01); C07D 249/14 (2006.01); C07D 487/04 (2006.01); C07K 16/22 (2006.01); C12N 15/113 (2010.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/122 (2013.01); A61K 31/155 (2013.01); A61K 31/343 (2013.01); A61K 31/37 (2013.01); A61K 31/4025 (2013.01); A61K 31/409 (2013.01); A61K 31/4196 (2013.01); A61K 31/4706 (2013.01); A61K 31/4709 (2013.01); A61K 31/49 (2013.01); A61K 38/17 (2013.01); A61K 38/179 (2013.01); A61K 39/3955 (2013.01); A61K 41/0057 (2013.01); A61K 45/06 (2013.01); A61P 27/02 (2018.01); C07D 249/14 (2013.01); C07D 487/04 (2013.01); C07K 16/22 (2013.01); C12N 15/1137 (2013.01); A61K 2039/505 (2013.01); C12N 2310/11 (2013.01); C12N 2320/31 (2013.01);
Abstract

The invention relates to a method of treatment of a patient with a ferrochelatase inhibitor, or a pharmaceutically acceptable salt thereof, or a derivative thereof. Also, the invention relates to a method of treatment of a patient with a ferrochelatase inhibitor that is a triazolopyrimidinone, or a derivative thereof, or a pharmaceutically acceptable salt thereof.

Find Patent Forward Citations

Loading…